Opioid Induced Constipation Drugs Market Report

Global Opioid Induced Constipation Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 25, 2021
  • PAGES：206
  • REPORT CODE：GMM653239
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Opioid Induced Constipation Drugs is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Opioid Induced Constipation Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Opioid Induced Constipation Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Opioid Induced Constipation Drugs Market Segmentations:

    By Players:

    • Nektar Therapeutics

    • Progenics Pharmaceuticals Inc

    • Purdue Pharma

    • Ironwood Pharmaceutical Inc

    • Mallinckrodt Pharmaceuticals

    • Shionogi & Co Ltd

    • Salix Pharmaceuticals Inc

    • Merck & Co Inc

    • Pfizer

    • AstraZeneca plc

    By Types:

    • Lubiprostone

    • Methyl Naltrexone Bromide

    • Naldemedine

    • Alvimopan

    • Other

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioid Induced Constipation Drugs Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Lubiprostone from 2014 to 2026

      • 1.3.2 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide from 2014 to 2026

      • 1.3.3 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Naldemedine from 2014 to 2026

      • 1.3.4 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Alvimopan from 2014 to 2026

      • 1.3.5 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

      • 1.4.2 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

      • 1.4.3 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Opioid Induced Constipation Drugs Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Opioid Induced Constipation Drugs by Major Types

      • 3.4.1 Opioid Induced Constipation Drugs Market Size and Growth Rate of Lubiprostone

      • 3.4.2 Opioid Induced Constipation Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide

      • 3.4.3 Opioid Induced Constipation Drugs Market Size and Growth Rate of Naldemedine

      • 3.4.4 Opioid Induced Constipation Drugs Market Size and Growth Rate of Alvimopan

      • 3.4.5 Opioid Induced Constipation Drugs Market Size and Growth Rate of Other

    4 Segmentation of Opioid Induced Constipation Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Opioid Induced Constipation Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Opioid Induced Constipation Drugs in Hospital Pharmacies

      • 4.4.2 Market Size and Growth Rate of Opioid Induced Constipation Drugs in Retail Pharmacies

      • 4.4.3 Market Size and Growth Rate of Opioid Induced Constipation Drugs in Online Pharmacies

    5 Market Analysis by Major Regions

    • 5.1 Global Opioid Induced Constipation Drugs Production Analysis by Major Regions

    • 5.2 Global Opioid Induced Constipation Drugs Consumption Analysis by Major Regions

    • 5.3 Global Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    6 Product Commodity of Opioid Induced Constipation Drugs Market in Major Countries

    • 6.1 Top 5 Export Countries in Opioid Induced Constipation Drugs market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Opioid Induced Constipation Drugs market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Opioid Induced Constipation Drugs market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Opioid Induced Constipation Drugs market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Opioid Induced Constipation Drugs market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Opioid Induced Constipation Drugs market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Opioid Induced Constipation Drugs Landscape Analysis

    • 7.1 North America Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 7.2 North America Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    • 7.3 North America Opioid Induced Constipation Drugs Landscape Analysis by Major Countries

      • 7.3.1 United States Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 7.3.2 Canada Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 7.3.3 Mexico Opioid Induced Constipation Drugs Market Volume and Growth Rate

    8 Europe Opioid Induced Constipation Drugs Landscape Analysis

    • 8.1 Europe Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 8.2 Europe Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    • 8.3 Europe Opioid Induced Constipation Drugs Landscape Analysis by Major Countries

      • 8.3.1 Germany Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.2 UK Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.3 France Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.4 Italy Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.6 Spain Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.7 Belgium Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.8 Poland Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.9 Russia Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.10 Turkey Opioid Induced Constipation Drugs Market Volume and Growth Rate

    9 Asia Pacific Opioid Induced Constipation Drugs Landscape Analysis

    • 9.1 Asia Pacific Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 9.2 Asia Pacific Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Opioid Induced Constipation Drugs Landscape Analysis by Major Countries

      • 9.3.1 China Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 9.3.2 Japan Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 9.3.4 India Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 9.3.6 South Korea Opioid Induced Constipation Drugs Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Opioid Induced Constipation Drugs Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Opioid Induced Constipation Drugs Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 10.3.2 Brazil Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 10.3.3 Nigeria Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 10.3.4 South Africa Opioid Induced Constipation Drugs Market Volume and Growth Rate 

      • 10.3.5 Argentina Opioid Induced Constipation Drugs Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Nektar Therapeutics

      • 11.1.1 Nektar Therapeutics Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Progenics Pharmaceuticals Inc

      • 11.2.1 Progenics Pharmaceuticals Inc Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Purdue Pharma

      • 11.3.1 Purdue Pharma Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Ironwood Pharmaceutical Inc

      • 11.4.1 Ironwood Pharmaceutical Inc Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Mallinckrodt Pharmaceuticals

      • 11.5.1 Mallinckrodt Pharmaceuticals Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Shionogi & Co Ltd

      • 11.6.1 Shionogi & Co Ltd Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Salix Pharmaceuticals Inc

      • 11.7.1 Salix Pharmaceuticals Inc Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Merck & Co Inc

      • 11.8.1 Merck & Co Inc Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Pfizer

      • 11.9.1 Pfizer Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 AstraZeneca plc

      • 11.10.1 AstraZeneca plc Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 83 Figures and 189 Tables)

    • Figure Product Picture

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Lubiprostone from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Naldemedine from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Alvimopan from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Opioid Induced Constipation Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Opioid Induced Constipation Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Opioid Induced Constipation Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Opioid Induced Constipation Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Lubiprostone

    • Figure Market Size and Growth Rate of Methyl Naltrexone Bromide

    • Figure Market Size and Growth Rate of Naldemedine

    • Figure Market Size and Growth Rate of Alvimopan

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Opioid Induced Constipation Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Opioid Induced Constipation Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Table Global Opioid Induced Constipation Drugs Production by Major Regions

    • Table Global Opioid Induced Constipation Drugs Production Share by Major Regions

    • Figure Global Opioid Induced Constipation Drugs Production Share by Major Regions in 2014

    • Figure Global Opioid Induced Constipation Drugs Production Share by Major Regions in 2018

    • Figure Global Opioid Induced Constipation Drugs Production Share by Major Regions in 2026

    • Table Global Opioid Induced Constipation Drugs Consumption by Major Regions

    • Table Global Opioid Induced Constipation Drugs Consumption Share by Major Regions

    • Figure Global Opioid Induced Constipation Drugs Consumption Share by Major Regions in 2014

    • Figure Global Opioid Induced Constipation Drugs Consumption Share by Major Regions in 2018

    • Figure Global Opioid Induced Constipation Drugs Consumption Share by Major Regions in 2026

    • Table North America Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Europe Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Opioid Induced Constipation Drugs market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Opioid Induced Constipation Drugs market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Opioid Induced Constipation Drugs market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Opioid Induced Constipation Drugs market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table North America Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Figure North America Opioid Induced Constipation Drugs Consumption Share by Types in 2014

    • Figure North America Opioid Induced Constipation Drugs Consumption Share by Types in 2018

    • Figure North America Opioid Induced Constipation Drugs Consumption Share by Types in 2026

    • Table North America Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table North America Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure North America Opioid Induced Constipation Drugs Consumption Share by End-Users in 2014

    • Figure North America Opioid Induced Constipation Drugs Consumption Share by End-Users in 2018

    • Figure North America Opioid Induced Constipation Drugs Consumption Share by End-Users in 2026

    • Table North America Opioid Induced Constipation Drugs Consumption by Major Countries from 2014 to 2026

    • Table North America Opioid Induced Constipation Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2014

    • Figure North America Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2018

    • Figure North America Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2026

    • Figure United States Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Europe Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Figure Europe Opioid Induced Constipation Drugs Consumption Share by Types in 2014

    • Figure Europe Opioid Induced Constipation Drugs Consumption Share by Types in 2018

    • Figure Europe Opioid Induced Constipation Drugs Consumption Share by Types in 2026

    • Table Europe Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Europe Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Opioid Induced Constipation Drugs Consumption Share by End-Users in 2014

    • Figure Europe Opioid Induced Constipation Drugs Consumption Share by End-Users in 2018

    • Figure Europe Opioid Induced Constipation Drugs Consumption Share by End-Users in 2026

    • Table Europe Opioid Induced Constipation Drugs Consumption by Major Countries from 2014 to 2026

    • Table Europe Opioid Induced Constipation Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2014

    • Figure Europe Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2018

    • Figure Europe Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2026

    • Figure Germany Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure France Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Asia Pacific Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Opioid Induced Constipation Drugs Consumption Share by Types in 2014

    • Figure Asia Pacific Opioid Induced Constipation Drugs Consumption Share by Types in 2018

    • Figure Asia Pacific Opioid Induced Constipation Drugs Consumption Share by Types in 2026

    • Table Asia Pacific Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Opioid Induced Constipation Drugs Consumption Share by End-Users in 2014

    • Figure Asia Pacific Opioid Induced Constipation Drugs Consumption Share by End-Users in 2018

    • Figure Asia Pacific Opioid Induced Constipation Drugs Consumption Share by End-Users in 2026

    • Table Asia Pacific Opioid Induced Constipation Drugs Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Opioid Induced Constipation Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2026

    • Figure China Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandOpioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure India Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2026

    • Figure GCC Countries Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Nektar Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nektar Therapeutics

    • Figure Sales and Growth Rate Analysis of Nektar Therapeutics

    • Figure Revenue and Market Share Analysis of Nektar Therapeutics

    • Table Product and Service Introduction of Nektar Therapeutics

    • Table Company Profile and Development Status of Progenics Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals Inc

    • Table Product and Service Introduction of Progenics Pharmaceuticals Inc

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of Ironwood Pharmaceutical Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceutical Inc

    • Figure Sales and Growth Rate Analysis of Ironwood Pharmaceutical Inc

    • Figure Revenue and Market Share Analysis of Ironwood Pharmaceutical Inc

    • Table Product and Service Introduction of Ironwood Pharmaceutical Inc

    • Table Company Profile and Development Status of Mallinckrodt Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Mallinckrodt Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Mallinckrodt Pharmaceuticals

    • Table Product and Service Introduction of Mallinckrodt Pharmaceuticals

    • Table Company Profile and Development Status of Shionogi & Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi & Co Ltd

    • Figure Sales and Growth Rate Analysis of Shionogi & Co Ltd

    • Figure Revenue and Market Share Analysis of Shionogi & Co Ltd

    • Table Product and Service Introduction of Shionogi & Co Ltd

    • Table Company Profile and Development Status of Salix Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Salix Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Salix Pharmaceuticals Inc

    • Table Product and Service Introduction of Salix Pharmaceuticals Inc

    • Table Company Profile and Development Status of Merck & Co Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co Inc

    • Figure Revenue and Market Share Analysis of Merck & Co Inc

    • Table Product and Service Introduction of Merck & Co Inc

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of AstraZeneca plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca plc

    • Figure Sales and Growth Rate Analysis of AstraZeneca plc

    • Figure Revenue and Market Share Analysis of AstraZeneca plc

    • Table Product and Service Introduction of AstraZeneca plc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US